Therapeutic Products Reporting Office
Since 2015, the NES Reporting Office for Essential Human Pharmaceuticals has been tasked with swiftly identifying supply shortages or disruptions of essential medicines. It takes appropriate action when the industry can no longer manage the situation. Suppliers of reportable medicines must notify the Reporting Office of any supply chain disruptions, allowing it to spot potential shortages early. For medicines subject to stockpiling obligations, disruptions can be temporarily avoided by releasing supplies from compulsory stocks. Compulsory stocks can cover two to four months of market demand, depending on the medicine.